254 related articles for article (PubMed ID: 34370977)
1. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.
Quan AML; Mah C; Krebs E; Zang X; Chen S; Althoff K; Armstrong W; Behrends CN; Dombrowski JC; Enns E; Feaster DJ; Gebo KA; Goedel WC; Golden M; Marshall BDL; Mehta SH; Pandya A; Schackman BR; Strathdee SA; Sullivan P; Tookes H; Nosyk B;
Lancet HIV; 2021 Sep; 8(9):e581-e590. PubMed ID: 34370977
[TBL] [Abstract][Full Text] [Related]
2. Ending the HIV epidemic in the USA: an economic modelling study in six cities.
Nosyk B; Zang X; Krebs E; Enns B; Min JE; Behrends CN; Del Rio C; Dombrowski JC; Feaster DJ; Golden M; Marshall BDL; Mehta SH; Metsch LR; Pandya A; Schackman BR; Shoptaw S; Strathdee SA;
Lancet HIV; 2020 Jul; 7(7):e491-e503. PubMed ID: 32145760
[TBL] [Abstract][Full Text] [Related]
3. Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.
Krebs E; Zang X; Enns B; Min JE; Behrends CN; Del Rio C; Dombrowski JC; Feaster DJ; Gebo KA; Marshall BDL; Mehta SH; Metsch LR; Pandya A; Schackman BR; Strathdee SA; Nosyk B;
J Infect Dis; 2020 Sep; 222(Suppl 5):S301-S311. PubMed ID: 32877548
[TBL] [Abstract][Full Text] [Related]
4. The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.
Krebs E; Zang X; Enns B; Min JE; Behrends CN; Del Rio C; Dombrowski JC; Feaster DJ; Gebo KA; Golden M; Marshall BDL; Metsch LR; Schackman BR; Shoptaw S; Strathdee SA; Nosyk B;
AIDS; 2020 Mar; 34(3):447-458. PubMed ID: 31794521
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
[TBL] [Abstract][Full Text] [Related]
6. Exploring Changes in Racial/Ethnic Disparities of HIV Diagnosis Rates Under the "Ending the HIV Epidemic: A Plan for America" Initiative.
McCree DH; Chesson H; Bradley ELP; Williams A; Gant Z; Geter A
Public Health Rep; 2020; 135(5):685-690. PubMed ID: 32762633
[TBL] [Abstract][Full Text] [Related]
7. Can the 'Ending the HIV Epidemic' initiative transition the USA towards HIV/AIDS epidemic control?
Zang X; Krebs E; Mah C; Min JE; Marshall BDL; Feaster DJ; Schackman BR; Metsch LR; Strathdee SA; Behrends CN; Nosyk B;
AIDS; 2020 Dec; 34(15):2325-2328. PubMed ID: 32796216
[TBL] [Abstract][Full Text] [Related]
8. Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities.
Krebs E; Enns E; Zang X; Mah CS; Quan AM; Behrends CN; Coljin C; Goedel W; Golden M; Marshall BDL; Metsch LR; Pandya A; Shoptaw S; Sullivan P; Tookes HE; Duarte HA; Min JE; Nosyk B;
AIDS; 2021 Nov; 35(13):2169-2179. PubMed ID: 34148987
[TBL] [Abstract][Full Text] [Related]
9. Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.
Zang X; Jalal H; Krebs E; Pandya A; Zhou H; Enns B; Nosyk B
Value Health; 2020 Dec; 23(12):1534-1542. PubMed ID: 33248508
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
Long EF; Brandeau ML; Owens DK
Ann Intern Med; 2010 Dec; 153(12):778-89. PubMed ID: 21173412
[TBL] [Abstract][Full Text] [Related]
11. Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities.
Zang X; Krebs E; Min JE; Pandya A; Marshall BDL; Schackman BR; Behrends CN; Feaster DJ; Nosyk B;
Med Decis Making; 2020 Jan; 40(1):3-16. PubMed ID: 31865849
[No Abstract] [Full Text] [Related]
12. Estimating the epidemiological impact of reaching the objectives of the Florida integrated HIV prevention and care plan in Miami-Dade County.
Zang X; Piske M; Humphrey L; Enns B; Sui Y; Marshall BDL; Goedel WC; Feaster DJ; Metsch LR; Sullivan PS; Tookes HE; Nosyk B
Lancet Reg Health Am; 2023 Nov; 27():100623. PubMed ID: 37928440
[TBL] [Abstract][Full Text] [Related]
13. Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies.
Kessler J; Myers JE; Nucifora KA; Mensah N; Kowalski A; Sweeney M; Toohey C; Khademi A; Shepard C; Cutler B; Braithwaite RS
PLoS One; 2013; 8(9):e73269. PubMed ID: 24058465
[TBL] [Abstract][Full Text] [Related]
14. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
[TBL] [Abstract][Full Text] [Related]
15. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
Long EF; Stavert RR
J Gen Intern Med; 2013 Oct; 28(10):1294-301. PubMed ID: 23588668
[TBL] [Abstract][Full Text] [Related]
16. "Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic.
Nosyk B; Krebs E; Zang X; Piske M; Enns B; Min JE; Behrends CN; Del Rio C; Feaster DJ; Golden M; Marshall BDL; Mehta SH; Meisel ZF; Metsch LR; Pandya A; Schackman BR; Shoptaw S; Strathdee SA
Clin Infect Dis; 2020 Dec; 71(11):2968-2971. PubMed ID: 32424416
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Alistar SS; Owens DK; Brandeau ML
PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
[TBL] [Abstract][Full Text] [Related]
18. Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.
Laxy M; Zhang P; Ng BP; Shao H; Ali MK; Albright A; Gregg EW
Appl Health Econ Health Policy; 2020 Oct; 18(5):713-726. PubMed ID: 32607728
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
